Geistlich Pharma AG   Report issue

For profit Phase 2
Founded: Wolhusen Switzerland (1851)
Status: No NME R&D (1851)

Organization Overview

First Clinical Trial
2015
NCT02313883
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Geistlich Pharma AG